Table 5.
Surgery | Sample (n) | Time post-op (weeks/years) | Changes in SCFAs | Study | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Acetate | Propionate | Butyrate | Isobutyrate | Valerate | Isovalerate | Total SCFA | ||||
26 | 1w | ↓ | ↔ | ↔ | ↔ | ↔ | ↔ | - | [70] | |
26 | 3w | ↓ | ↔ | ↔ | ↑ | ↔ | ↑ | - | [70] | |
RYGB | 14 | 4w | ↓ | ↓ | ↓ | - | ↓ | - | ↓ | [91] |
73 | 6w | ↓ | ↓ | ↓ | ↑ | ↔ | ↑ | ↓ | [74•] | |
7 | 6w | ↔ | ↔ | ↔ | ↑ | ↔ | ↑ | ↔ | [93] | |
9 | 12w | ↔ | ↔ | ↔ | ↑ | - | ↑ | - | [93] | |
14 | 1w | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ | - | [70] | |
SG | 14 | 3w | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ | - | [70] |
8 | 4w | ↓ | ↓ | ↓ | - | - | - | ↓ | [91] | |
17 | 6w | ↓ | ↓ | ↓ | ↑ | - | ↑ | ↓ | [74•] | |
SG/BDP/bypass | 6/2/1 | 4y | ↓ | ↓ | ↓ | - | - | - | - | [94] |
“↑” – higher concentration vs before BS, “↓” – lower concentration vs before BS, “↔“ – no significant changes vs before BS, “-” – no data